How many patents does
Incyte Holdings Corporation have?
patents
1,922
families
68
granted
507
applications
1,415
US
327
EP
150
JP
90
CN
87
KR
65
WO
52
RoW
1,151
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Incyte Holdings Corporation
Top ten assignees appearing on patents
2009 - 2018
| incyte | 1236 |
| incyte holdings corporation | 558 |
| lncyte holdings corporation | 2 |
| insajt korporejshn | 2 |
| fresh express | 2 |
| halosource | 1 |
| incyte holdinges corporation | 1 |
2009
| incyte | 47 |
| insajt korporejshn | 1 |
2018
| incyte holdings corporation | 149 |
| incyte | 63 |
Incyte Holdings Corporation
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus ki… 🛈 | 156 | 2005 |
| 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | 89 | 2008 |
| piperidin-4-yl azetidine derivatives as jak1 inhibitors | 74 | 2010 |
| processes for preparing jak inhibitors and related intermediate compounds | 73 | 2009 |
| salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazo… 🛈 | 69 | 2007 |
| heterocyclylamines as pi3k inhibitors | 67 | 2011 |
| imidazotriazines and imidazopyrimidines as kinase inhibitors | 63 | 2006 |
| azetidine and cyclobutane derivatives as jak inhibitors | 58 | 2008 |
| substituted tricyclic compounds as fgfr inhibitors | 56 | 2012 |
| pyrimidinones as pi3k inhibitors | 55 | 2009 |